Virginia Retirement Systems Et Al Neurocrine Biosciences Inc Transaction History

Virginia Retirement Systems Et Al

$14.2 Billion
Q2 2025

A detailed history of Virginia Retirement Systems Et Al transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Virginia Retirement Systems Et Al holds 85,123 shares of NBIX stock, worth $11 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares

85,123

Previous 419,623 79.71%

Holding current value

$11 Million

Previous $46.4 Million 76.95%

% of portfolio

0.08%

Previous 0.35%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 29, 2025	SELL	$87.54 - $128.18 $29.3 Million - $42.9 Million	-334,500 Reduced 79.71%	85,123 $10.7 Million
Q1 2025 Jul 16, 2025	SELL	$107.22 - $153.29 $19.4 Million - $27.8 Million	-181,200 Reduced 30.16%	419,623 $46.4 Million
Q3 2023 Jan 02, 2024	BUY	$94.02 - $117.1 $42.9 Million - $53.5 Million	456,800 Added 317.17%	600,823 $67.6 Million
Q2 2023 Aug 22, 2023	SELL	$89.53 - $104.87 $3.25 Million - $3.81 Million	-36,300 Reduced 20.13%	144,023 $13.6 Million
Q1 2023 Jul 11, 2023	BUY	$94.11 - $123.02 $331,549 - $433,399	3,523 Added 1.99%	180,323 $18.3 Million
Q4 2022 May 17, 2023	SELL	$106.72 - $127.06 $661,664 - $787,772	-6,200 Reduced 3.39%	176,800 $21.1 Billion
Q3 2022 May 16, 2023	BUY	$92.03 - $107.81 $16.8 Million - $19.7 Million	183,000 New	183,000 $19.4 Billion
Q2 2021 Aug 13, 2021	SELL	$89.43 - $102.27 $241,461 - $276,129	-2,700 Closed	0 $0
Q1 2021 Apr 30, 2021	BUY	$87.57 - $119.4 $236,438 - $322,380	2,700 New	2,700 $263,000
Q3 2020 Nov 12, 2020	SELL	$96.16 - $135.15 $1.41 Million - $1.99 Million	-14,700 Closed	0 $0
Q2 2020 Aug 12, 2020	BUY	$85.09 - $130.36 $757,301 - $1.16 Million	8,900 Added 153.45%	14,700 $1.79 Million
Q1 2020 May 12, 2020	SELL	$75.11 - $113.76 $1.51 Million - $2.29 Million	-20,100 Reduced 77.61%	5,800 $502,000
Q4 2019 Jan 27, 2020	BUY	$86.8 - $118.57 $772,520 - $1.06 Million	8,900 Added 52.35%	25,900 $2.78 Million
Q3 2019 Oct 22, 2019	BUY	$83.82 - $101.5 $16,764 - $20,300	200 Added 1.19%	17,000 $1.53 Million
Q2 2019 Jul 26, 2019	BUY	$72.24 - $91.27 $570,696 - $721,033	7,900 Added 88.76%	16,800 $1.42 Million
Q1 2019 Apr 25, 2019	BUY	$69.31 - $91.53 $187,137 - $247,131	2,700 Added 43.55%	8,900 $784,000
Q2 2018 Aug 03, 2018	BUY	$75.3 - $105.99 $466,860 - $657,138	6,200 New	6,200 $609,000

Others Institutions Holding NBIX

# of Institutions

645

Shares Held

96.8M

Call Options Held

743K

Put Options Held

508K

View Full List

About NEUROCRINE BIOSCIENCES INC

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $12.3B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

More about NBIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Virginia Retirement Systems Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Virginia Retirement Systems Et Al with notifications on news.

Account

Virginia Retirement Systems Et Al Neurocrine Biosciences Inc Transaction History